MTI Ltd. is a Health Care company. Its directors and officers file their transactions with EDINET (Japan FSA). From 18 October 2025 to 18 October 2026, the disclosure feed for MTI Ltd. logged 3 filings by 1 insider.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
For context, the typical company on the same exchange (median of 3,419 companies) published 3 filings over the same period, against 3 filings here.
Insider buying of MTI Ltd. has been absent for the past year. Between a trade and the moment it shows up on EDINET (Japan FSA), the median delay is 7 days. That lag is the time during which only the insider knows about the trade.
Elsewhere in the same sector, our signals recently picked up insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Every figure here comes from the filings published by EDINET (Japan FSA) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended September 2025 · cache
10 of 10 declarations
MTI Ltd. is a Japanese company specializing in the health and pharmaceutical sector. It is listed on the XTKS market.